Region: Europe

Changed political climate may influence latest implementer v SEP licensor antitrust action

Although u-blox's litigation against InterDigital raises familiar legal arguments, questions remain about the impact of a new antitrust chief and lack of SEP/FRAND policy statement

17 January 2023

Nokia’s UK victory over Oppo sets stage for London FRAND trial

Finnish SEP owner enjoys more success in Europe, but decisions elsewhere could be more important

16 January 2023

Small UK company on the verge of windfall from potential Samsung settlement

Nanoco Technology counts IP as a “key strength” with manufacturing royalties and patent licence fees as a small but growing part of its revenue base

16 January 2023

Opus audio codec pool launches with royalty discount for early adopters

Pool operator Vectis IP offers a licence to 300 Fraunhofer and Dolby patents for €15c per hardware device – but those quick to move unlock a 33% discount

16 January 2023

What BioNTech’s £362 million AI acquisition says about the future of life sciences IP strategies

The convergence of tech and biopharma has major implications for patent professionals

13 January 2023

Apple extends in-house patent team to Europe, reflecting region’s rising importance

Sonja Bohusch has been appointed Senior Legal Counsel, IP Litigation

12 January 2023

Conflicting interests: refusing NDAs in FRAND negotiations

Featured in SEP/FRAND Hub

Düsseldorf courts provide clarity on the consequences of failing to agree on an NDA. While it is generally incumbent on implementers to negotiate and conclude an NDA with the SEP holder, refusal to enter into one does not necessarily make the implementer a non-willing licensee.

12 January 2023

Key provisions and IP considerations of the incoming EU CHIPS Act

R&D collaboration entails risk and it is therefore vital for companies to start thinking about the best strategies to adopt

11 January 2023

InterDigital’s chief licensing officer shares her SEP takeaways of 2022

Eeva Hakoranta reflects on holdout, policy moves and the benefits of arbitration as we move into the new year

10 January 2023

F-Star buyout delay shows growing national security disruption to patent dealmaking

Purchase by Sino Biopharm subsidiary has been put on hold by US authorities

04 January 2023

Unlock unlimited access to all IAM content